- PTJ ONLINE トップ
- 行政資料
行政資料
- 薬生薬審発0627第1号「「潜在的発がんリスクを低減するための医薬品中DNA反応性(変異原性) 不純物の評価及び管理ガイドラインについて」の一部改正について」 2018/06/27
- 薬生薬審発0627第1号「「潜在的発がんリスクを低減するための医薬品中DNA反応性(変異原性)」 2018/06/27
- Health Canada, "Notice to industry: Aligned reviews between Health Canada and health technology assessment organizations" 2018/06/22
- PIC/S "GUIDELINE ON SETTING HEALTH BASED EXPOSURE LIMITS FOR USE IN RISK IDENTIFICATION IN THE MANUFACTURE OF DIFFERENT MEDICINAL PRODUCTS IN SHARED FACILITIES" 2018/06/21
- PIC/S "GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE" 2018/06/20
- PIC/S "GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING PRACTICE FOR EXCIPIENTS OF MEDICINAL PRODUCTS FOR HUMAN USE" 2018/06/20
- AIDE-MEMOIRE on CROSS-CONTAMINATION IN SHARED FACILITIES 2018/06/20
- PIC/S GMP Guide Part 1 (PE 009-14) 2018/06/20
- PIC/S "GUIDANCE GMP INSPECTION RELIANCE" 2018/06/15
- S9 Nonclinical Evaluation for Anticancer Pharmaceuticals Questions and Answers Guidance for Industry 2018/06/15